Abstract

Oxidative stress is a defining molecular hallmark of diabetes mellitus and its complications. Both type 1 and type 2 
diabetes are characterized by excessive production of reactive oxygen species (ROS), chronic low-grade 
inflammation, mitochondrial dysfunction, and impaired antioxidant defenses. Although oxidative stress has long 
been recognized as a pathogenic feature of hyperglycemia, recent mechanistic studies reveal far more intricate 
networks involving redox signaling, metabolic inflexibility, immune activation, and organelle crosstalk. These 
pathways not only contribute to beta-cell dysfunction and insulin resistance but also underlie the development of 
cardiovascular disease, nephropathy, neuropathy, hepatosteatosis, and retinopathy. At the same time, evidence 
increasingly suggests that antioxidant defense failure in diabetes extends beyond simple depletion of antioxidant 
enzymes. Emerging insights highlight structural modification of antioxidant proteins, dysregulation of 
transcription factors such as Nrf2, alterations in glutathione metabolism, impaired mitochondrial biogenesis, and 
persistent inflammatory signaling that overwhelms physiological redox buffering systems. This review 
synthesizes current understanding of oxidative stress pathways in diabetes, focusing on novel insights into the 
mechanisms of antioxidant failure and their implications for therapeutic innovation. By integrating findings from 
cell biology, systems metabolism, and clinical research, we outline key redox circuits implicated in diabetes 
progression and offer perspectives on new antioxidant strategies that may prove more effective than conventional 
nutrient-based supplements.